Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Livingstone Health HoldingsSGX:PRH EBITDA Margin % is 4.59% as of Mar. 2026, which is 3% below its 10-year median of 4.75. The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Livingstone Health Holdings ranks worse than 58.41% on this metric.
Livingstone Health Holdings (SGX:PRH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Livingstone Health Holdings EBITDA Margin % Related Terms
Livingstone Health Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:PRH vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Livingstone Health Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Livingstone Health Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Livingstone Health Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Livingstone Health Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Livingstone Health Holdings (SGX:PRH) has a EBITDA Margin % of 4.59% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Livingstone Health Holdings and its competitors. This is near median its historical median of 4.75. According to the industry distribution chart, Livingstone Health Holdings ranks #389 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 58.4%.
Is Livingstone Health Holdings' EBITDA Margin % too high?
Livingstone Health Holdings' current EBITDA Margin % of 4.59% is near median its 10-year median of 4.75. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Livingstone Health Holdings' value of 4.59% is 55.2% below this industry median. Based on the distribution chart, Livingstone Health Holdings ranks #389 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Livingstone Health Holdings' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Livingstone Health Holdings ranks #389 out of 666 companies for EBITDA Margin %. This places Livingstone Health Holdings in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Livingstone Health Holdings' value of 4.59% is 55.2% below this benchmark. While the company's 10-year median is 4.75 vs. the industry median of 10.24, Livingstone Health Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Livingstone Health Holdings's current EBITDA Margin % of 4.59% is 55.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Livingstone Health Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Livingstone Health Holdings's current EBITDA Margin % is 4.59%, which is near median its own 10-year median of 4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Livingstone Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, Livingstone Health Holdings (SGX:PRH) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.02, compared to a current price of S$0.03 — trading 35% above its estimated fair value. The current EBITDA Margin % is 4.59%, which is near median its 10-year median of 4.75 and 55.2% below the Healthcare Providers & Services industry median of 10.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Livingstone Health Holdings (SGX:PRH), the current EBITDA Margin % is 4.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Livingstone Health Holdings Ltd through its subsidiaries, is engaged in providing medical treatment and consultancy services. It is engaged in providing healthcare facilities through its clinics. The services offered by the company comprise Orthopaedic, Aesthetics and Wellness, Pain and Anaesthesiology, Dermatology, and Family Medicine among others. The company's reportable segments are Specialist Healthcare, Primary Healthcare, and Others. The majority of its revenue is generated from the Specialist Healthcare segment which includes services provided by healthcare professionals who focus on a specific field of medicine such as Dermatology, Anaesthesiology and Pain Management, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:PRH has been successfully added to your 
